A randomized, phase III study (AGO-OVAR-9, GINECO-TCG, NSGO-OC-0102): Gemcitabine-paclitaxel-carboplatin versus paclitaxel-carboplatin as first-line treatment of ovarian cancer (OC): Survival of FIGO stage I-IIA patients
2009 ◽
Vol 27
(15_suppl)
◽
pp. LBA5510-LBA5510
Keyword(s):
LBA5510 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]
2012 ◽
Vol 30
(15_suppl)
◽
pp. 3-3
◽
Keyword(s):
2009 ◽
Vol 27
(15_suppl)
◽
pp. LBA5509-LBA5509
2012 ◽
Vol 30
(15_suppl)
◽
pp. LBA5000-LBA5000
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. LBA3506-LBA3506
Keyword(s):
Keyword(s):
2018 ◽
Vol 48
(8)
◽
pp. 777-780
◽
Keyword(s):
Keyword(s):